Novartis AG Common Stock (NVS)

Short-Term Debt

$9.86B

Quarterly · Period ending: · USD

NVS logo

NVS Short-Term Debt

Latest reported$9.86B
NVS Quarterly Short-Term Debt ($3.67B → $9.86B)
High-resolution chart · PNG

NVS short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
9,862,039,000
7,888,000,000
5,784,000,000
7,784,000,000
8,573,000,000
8,043,000,000
8,324,000,000
6,813,000,000
7,764,000,000
8,564,000,000
6,313,987,567
5,668,000,000
8,536,000,000
7,219,000,000
6,127,014,827
7,303,000,000
7,303,000,000
6,968,000,000
6,502,000,000
9,614,000,000
9,354,000,000
10,444,000,000
9,877,000,000
9,994,000,000
9,133,000,000
11,205,000,000
7,091,969,348
8,283,000,000
8,151,000,000
7,701,000,000
9,620,000,000
9,177,000,000
9,596,000,000
10,911,000,000
5,201,000,000
6,997,000,000
7,562,000,000
8,324,000,000
8,055,000,000
8,307,000,000
10,092,000,000
11,629,000,000
5,604,000,000
9,289,000,000
9,973,000,000
10,279,000,000
6,612,000,000
6,937,000,000
7,556,000,000
6,009,000,000
6,776,000,000
7,656,000,000
7,256,000,000
9,334,000,000
5,945,000,000
5,017,000,000
8,878,000,000
10,698,000,000
6,374,000,000
10,154,000,000
13,581,000,000
16,581,000,000
8,583,000,000
12,631,000,000
5,408,000,000
4,484,000,000
5,233,000,000
5,660,000,000
4,673,000,000
4,474,000,000
4,857,000,000
8,741,000,000
8,559,000,000
5,731,000,000
4,916,000,000
6,576,000,000
6,819,000,000
6,689,000,000
6,560,000,000
7,258,000,000
7,809,000,000
6,750,000,000
6,890,000,000
4,467,000,000
5,201,000,000
3,455,000,000
3,051,000,000
2,616,000,000
2,883,000,000
3,399,000,000
2,280,000,000
2,582,000,000
3,948,000,000
2,981,000,000
2,532,000,000
3,330,000,000
3,454,000,000
3,062,000,000
2,948,000,000
2,226,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.